MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RYTM has $480,196K in assets. $210,170K in debts. $54,301K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
440.73%
Quick Ratio
416.42%
Cash Ratio
51.26%
Debt to Asset Ratio
43.77%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series a convertible preferred s...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
54,301
Short-term investments
334,648
Accounts receivable, net
26,081
Inventory
25,753
Prepaid expenses and other current assets
26,133
Total current assets
466,916
Property and equipment, net
1,104
Right-of-use asset
3,049
Intangible assets, net
5,319
Restricted cash
522
Other long-term assets
3,286
Total assets
480,196
Accounts payable
13,947
Accrued expenses and other current liabilities
83,855
Other current liability - lg chem
0
Deferred revenue
194
Deferred royalty obligation, current
7,296
Lease liability
650
Total current liabilities
105,942
Deferred royalty obligation
100,886
Lease liability, non-current
3,342
Derivative liability
0
Total liabilities
210,170
Series a convertible preferred stock, 0.001 par value 150,000 shares authorized 132,500 and 150,000 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively. liquidation preference of 132,500 and 150,000 as of december 31, 2025, and december 31, 2024, respectively
130,957
Common stock, 0.001 par value 120,000,000 shares authorized 67,205,321 and 62,390,654 shares issued and outstanding at december31, 2025 and december31, 2024, respectively
67
Additional paid-in capital
1,491,675
Accumulated other comprehensive (loss) income
-796
Accumulated deficit
-1,351,877
Total stockholders equity
139,069
Total liabilities, convertible preferred stock and stockholders equity
480,196
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$334,648K Cash and cashequivalents$54,301K Prepaid expenses andother current assets$26,133K Accounts receivable, net$26,081K Inventory$25,753K Total current assets$466,916K Intangible assets, net$5,319K Other long-termassets$3,286K Right-of-use asset$3,049K Property and equipment,net$1,104K Restricted cash$522K Total assets$480,196K Total liabilities,convertible preferred stock...$480,196K Total liabilities$210,170K Total stockholdersequity$139,069K Series a convertiblepreferred stock, 0.001 par...$130,957K Accumulated deficit-$1,351,877K Accumulated othercomprehensive (loss) income-$796K Total currentliabilities$105,942K Deferred royaltyobligation$100,886K Lease liability,non-current$3,342K Additional paid-in capital$1,491,675K Common stock, 0.001 parvalue 120,000,000...$67K Accrued expenses andother current...$83,855K Accounts payable$13,947K Deferred royaltyobligation, current$7,296K Lease liability$650K Deferred revenue$194K

RHYTHM PHARMACEUTICALS, INC. (RYTM)

RHYTHM PHARMACEUTICALS, INC. (RYTM)